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clewilmd, Dhio 
Adbcrion of circuloring lcukocytcs md pkdclcts to lhc blood 
veogl wall is ao essential component of acute and chronic 
events io variw axonmy artcry dkcw prucessw. including 
atkcroacknxii thmmbc& resten& nftrr pcrcubmneuur 
~mnsh~mi~~l comonry aogioplasly. reperfuskm injury and PI- 
log&i vaolopathy in cmdii tn~ns+lnnt recipicnls. In wch 
zap of cell-cell binding and cell-envaccllulilr muhix hind@ 
cell adhcsica molecules, includii inQii.o nelcctins md 
irnmunoghbvlin sqcrlamili~ mediate these pmeegwr 
lntegrtns 
Imegriruwerc named by Richard Hynes in 1987 (I) for the 
family of itdegral membrane rcccpton thuughl to “integmb” 
the qmskclc~n of 011~ nxll with fhar uf another cell or with 
cnmcclhdar mati. lkaux L number uf the pmteins were 
idatilled before the rcmgoition of ao inlqrin superfamily. 
some ofthe subunits awl members haw multiple names (Table 
I). The &grins comprise a superfamily of bcwodimcr 
tmcamcmbmoe pmtcior compacd of noomvalendy awci- 
ated n. and &subunits (pig. I) (2). Rewndy. eight ~3aubuoits 
nod 12 a-subuoits have been identified. and gcoomic analysis 
suggcstr thal there may bc more integin sobunib (3). lnlcgrinr 
am subdii into scvcml subfamilies bawd on the sharing of 
o commou mbunit by various o.subooi~r Among them 
rubfamilics rhrcc main gwup arr widely kmwn bcnw of 
their cxlicr discovcrv than odxn. First. n!!y lllc appt’utiirly 
onrigvn (VLA) intcg& has a &-subunit and are named 
bccaurc thev were Rat id&tied on T bmphowten “ve:rv late 
afwr” mitu& sdmulatioo (4). Semnd, /c&&c in&Jns 
share a &-suhunit. The &-subfamily of lcukcq~c inlcgrins 
~nsktr of hetcrrdimas &crrcd IO as iyqlwx@ function- 
w.wiwd nr&a~ (LFA).I (ilka komm a8 o,& or CDlln! 
awl). Mx-I (Il.&. CD1 ItKDP or CR3) nod p15w5 (a&, 
CDllcKDIX) (5). Thii, qcetfJwi~irs have J &subunil. The 
&ubfamdy of imcgdra comdsls of the platelet glycoprotein 
IlMllr mmplca nod the viuomxtin rcccptor (Table 1) (6). 
Many intcgrios that bind to matrix mol~xulcs recognize the 
trip@& ArgGly-Asp (RGD) (7). These ROD sequcnccs arc 
found within a numba of matrix prowins. includiw fibrorxc- 
tin. librinogcn, thmmlqnmdii ~itmncctin, lam& nod type 
I collagn. although recogoitioo of lhcse morrix proteins by 
intcgriw is not always mediated by ibeir RGD sequcnce~. Tbc 
~3,. and some 8,.intcgrins recognize RGD sequences as bind- 
iw sites of thge oroleha but fbc B&twins are not gener- 
& thought to r&nize the RGDmotif (&9). The ant 
number of innerin.sare memhenofthc 13,. or VL4 subfamily, 
which U.Z diskbulcd in various kindi’of cells. The ViA 
inkgrins medii cell adhaion to a number of proteins found 
in cxtraeellular matrix, ineluding collag%~, fibmnatin and 
laminin. The &or leukocyte intcgrin subfamily appears in the 
leukocyw restrictively (10.11). The ligands identilicd for the 
leukocyte inrcgrins arc shown in Table I. ‘lhlhese l ukocy.2 
intcgrins show diScrent distributions (I $13): LFA is found on 
al! leukwy‘cc_ and Mac-1 and plSR195 nre present in mycloid 
cells and mowxylcs. MaoI is abundant in cclk of the mycloid 
lineage, whereas ~150195 is most bighiy cxprnaed by tissue 
macmpbages. GPlIb/lIla (a,&,, CD41/CD61) is primwIly 
found oo om@myq~cs and platelets. Recently, Gpllb/llln 
has also ban sbwm to be expressed by certain tomor cells 
(19.Tbe activation of GPllblllla by variooragon~ inelodiy 
adenmine dipbosphatc (ADP). epinephrbm. tbrombm and 
Tbii-~ivation mm also pwmita G~llb/lila to bi~&mmc- 
tin and van Willebnmd factor fvWI3. medialne tbc adhesion 
of platelets to eodotbcliom or ihe &eodoth&l matrix (l-5). 
The ~itrooectb~ recqtor (INI& a.& or CDSIICD6.1) bus the 
widest distriitkm, appearing on most meseocitymal cells as 
well I on maoy other kinds of cells (7). The tihuoectio 
ttb&, tbmmbqcmdio: vohWi&bmod &or and 0; 
tcopomin. 
s9kctins 
The rekclins have been called by nuious oames acmrdiy 
to their disemcp (16). Lselecdn bos been termed tbe 
lympboeyte-homing receptor, ~pp. Leu-8, loukoqie adbe- 
aion molecule (LAM)-I, leukocyte cndotbelial all adk.sioo 
molecule (LECAM)-1 and MElc14. E&cctio was called 
cndotbclial leukocyte adhesiun molsule @LAM)-I. P- 
selectin WBS called CD62, mule membrane protein of mo 
keub ous 140 biir (GMP Ire) and phtekt &.-ados 
dependent grnvk cxtemol membmnc pmcCin (PADGEM). A 
slsndprdmmad~turcbss~oagecdon(l7~whirbdgi~ 
uhfmnilynvmberwcordiitotbeceUtyponwbichitwra 
orl@dly bleotii Eaelectb~ (eododtelimo), Pa&tin (plate. 
lets) mod lakctin (lymphoqw.) (Tabk 2). 
Tbc sclectbtsam mmpwd of o lcctin domain. ao epitbelial 
8mwtb factor (EGP)-likc region and mnoplcmero rcgohtoay. 
libe mod&a (16.18) (Pii 2). P- nod Eselcctins bind to 
common sitcs ct cubobydmter, including ~iQbod L&s x 
(sle’~mlated structorc~, sulfated pdy.whaddcs (hepatIo. 
fucoidao) sod pbmphated moocacbnrbkr and pd~ar- 
kkr (141923. L-s&tin binds to mucin-libe endotbelial 
&opmteior (21). E-s&& hasken known to participate in 
the odbcsioo ofoxwopbils, monocyier and a subpqndation of 
-oty T iympbcqtes to cndotbetird cells that have been 
activated by cytokiws (interteokiil, tumor occmsis facto@ 
nod bactotial endotoxh (22). Eosinophils (23) muI bwpbilr 
(24) may also bind to endothelium dma@ E-s,leclin. P 
selecti (CD62) is present in dpha-gramder of plate:cls at nst 
(25) and W&C!-Pal& bodies (26) of cndothclCi cdb. Ott 
activatiun by thmmbbt or other meditttarr. P-xicctit; is mpidly 
redistributed to the rutfacxs uf platelets and cnrlotbclial C&S 
(27.2%). P-s&tin htts been shown to hind to diLrcot twcs of 
&kt!&~_ ineluding ttetttrophils and mutt~ycs (27.2uN). 
thus mediating platelet-leukocyte afid enduth.:lial cull- 
leukocyte bnerttciir. L-&ctitt. fond on nut cinvlilting 
btmtatt lympbwytcs. ttettlmphi~ ttttd monocyw. wus initialiy 
implicated in lymphocyte homing to rwxtdt~q lymphuid tis 
Rgwe2. Schematic pescntatiott of E-. P. tmd 1.s&ctia slwn+g an 
nmkto tennina lcctin dwtaii. cpk!cmtal growth factor (EGFI-Iikc 
ngbm, dirtetc number of romplcmrnt binding-like prutcbu. 
te t@on and a cymplasmic tail. CR = cmnplcmcnt 
tegtttatcay-like m&h (Mcdificd horn lkvi!aqequr MP. Endudwliat- 
tettlocypc Mlbesio” mvkculc% An”” Bc” tmm”lwl 1993.11:767-LltN 
Reprimed vilb pntt!Sion.) 
SULS (31X). Recrnl studiis (33.34) in viva have sugcsted that 
L-xlcctin h;r* also prtic.patd it) lcukcqte rolling on the 
vesxl wall as well us tbc c~trawatkm pmcess during inllam- 
matba. Unlike the utber hw selectins. L-sclectin is mnnitu- 
lively cxprcwd and shed from the nil sutfttce nithitt minutes 
afwr I.wkvc~tc ttctiutiun (3%. 
lmmunoglobulin Superfamily 
In the I9+% it became ~pptirent that nttain members of 
the immunnJlnbtdin superfamily. including intmrelbtku adhe- 
sion mulwle (ICA,M)-I. ICAM- and nscttlm cell adhcsiott 
molwulc lVCAMI.1. ale hv mles not onlv in adberion but 
a!_w in t~nrittti&o~ oi bl&d lcttkocqc~ (36) (T;lblr 3). 
ICAM-I lCD.541 ttnd ICAM- tttr closelv related in stmctttre 
and fun&n (Fii. 3;. ICAM-I is widely frptxad by hemato- 
plictic and nonhetnttropoictie cclk and is tt primary lffnd fur 
LFA-I (37). ICAM- is also P liind fcr LFA-1. and its 
dirtributiun in T, B nnd monobktstic ell lines is sttggcstcd by 
the 6ccneratitm of its messqer ribattucleic acid (38). 
Regulation of ICAM-I exp~*rion cat be xhicved $ 
trettttncnt with roecific cvmkines ftumor ttecrcsis fttctor 
~F]-II. interlet& and i&rleukin~[tL]-1) or by adhm-cr 
to mmis mubim sttcb PS tibmnectin 139.40). Like E-selectin. 
ICAY-I i rxprewd in abundance ob &c~~lar cttdothclium 
wcr.ll hottm after stimulation by interleukin-I or tumor 
ttccrds factor (39.40). Hmvewr. the pattern of qw.sion of 
ICAM-I shows difTerences fmm thrt of E-selectin (Ttthlcs 2 
and 3). 
Rcccntly. it was shown that B ligtmd for a& (VLAJ: 
CD49diCD29l.integtin is one of the immdnoglobttlin ruprr- 
fttmily membca. VCAM-I (II). Endnlhclial VCAM-I 1~9s fint 
shown to support the adhesion of lymphocytes and tttonacytcs 
through an interactinn with the inngdn a.@t (42.43). In 
addition. adhcriott of eusinophils (44) and bwphils. but not 
ncutmphilr (45). to a&ad endothelium also appears to 
invoke VCAM-I. VCAM-I k aka expressed cm rvenl non- 
vwdar cdl fyper (46). On stimuklion by IL1 and TNF-a, 
VCAM.1 on the cndothelkl cdl surfaces ir up+‘cStdatr.d, and 
maximal activity is reached by 6 to 12 h (47). 
Plaekt cndothelid cell adhesion nwkculc (PECAM)-I 
(CD31) htx hem shown to medktc endothelkl cdl-cell intaro 
limr (4.S) as a bonx%ypk ceil adhesion mdecuk. in additica its 
pse31Eeonpktekl*Tpelkandntonccy%sq+xtsthatittttay 
have an impmtant rde in ettdothcSnlkatii. thm&osb (49) and 
tmmmdatheliil migmtbm of leukccyler (50). 
Other Cellular Adhedon Molecules 
The cadherin wperfamily is a Smup of proteins for main. 
taking Ii&t @tp junctions and intemlluhtr spainS In adult 
tiwe (5152). Frotea&ms mnatitute a large protein family 
with SlymsaminoSlyean aide chains mediating lyntphoqte 
bindInS to mttcrmal high endothdiii venuks (53) and cpithelial 
cells bindin lo mlk#enr 1, ill and V. fibmttectin and them- 
borpmdin (54). Flatekt OPibiX mmpkx, the ttwt familiar 
cell adhesion mokctde of the mucht family, contdtm a 
thmmbin.bindi~ site and a van Wilkbnnd factwbindiqslte 
(SS), which is tespensibk for initial binding of the pktckt at 
rmt to slhendothelium (56). 
ilolc in Cururwy Artery Disease 
Atftnarcfero4fs 
The basic pathogenesis of the atherwkmtic process has 
teen desertid in detail by Row (57) and updated recently 
(58). lbc fundamentsl athemxkmtk lesion is the fibmfatty 
plaque, which s to thrombosk and cakitkadon and 
ulrimatcly raulh in narmwing of the arterks. The DCII mm- 
ptlnents in the %hcmsckmtic kriott conskl plincipldiy cd 
smmth mu& cells. tttacrcphags and some T lyqhqtes 
(59). The mkr of a numher of cell adhesion moleculea in thit 
mmpla intemctim are critkal (Fii 4). The adhesion pmteins 
expressed on the vascular endothdial cell auface fall into MO 
clasw the rckctbts (E9kctin. P-skctin) and tbc immtw 
@btdbt family (VCAM-I. ICAM-I). Recently, the mk ofceil 
all&m mdeakr in kukayto-maocbclial ail intenctbtts 
and te~d&m of kuboqlc migetion was ptukcly wiemed 
byManarpdShm(60).Onku~s~hcA-i.~ilad 
~lStlK5 bttc&tts and Lsekctk baw been implii in 
human athemms, VCAM-I k expressed not c&y on cttdotiw 
iiai cells but aka an macmphages md mtmth murder (6P 
CSyman 41 6i. (62) d~ntottstnted that smooth musk aik of 
the bhmd vepscl cxpmss vatiw &-integins that appear to 
mcdiak cell intmactions with the cmtnccilula~ matrix. Bottd- 
ma” et al. (63) showed thaw addition @I ROD pptidcr ot 
antibody agaimt tibmncctln dccrcscd migmtim of smtmth 
murk celtb 
~@qenkmkofllpidshlrbeenstudkdeuenskelyht 
nthcmsclaosir. The lipids prtkip~te in a cyck of local 
qiokhw ekbor&on. ‘Ibc fycokitter, swh LI IL1 and TNi% 
rtiwd6 owtoqes and macropiuS (66). Mrmphases can 
modify bw density iipopmtcin (LDI.) by par&timt (65). it 
k sugpgcd that ddircd LDL has cyxotmk &cts on endo- 
thelld mtd msenc~J cellrand k mponsibk forthecmtml 
nsnuir that ftequmtly exkn in advawd sthaxckmtii 
dnauca Osidked LDL also amolitkr the rclc~~c of iwl 
&t&a eiatamted by endatheikl cdk IL1 tmd TNF-a 
cause a rapid induction of the adhesion rmkculcs E-sekctbt. 
VCAM-I and ICAM-I. whenas intwfcmn-7 upqd~tta 
ICAM- over a loqer period, -10 IO 24 h (4&66). 
Li et ai. (67) shard that ~thcmgcttic diets an induce 
VCAM-I apr&on on vasmkr ettdothelial aik as well iIs 
smooth muck celk in intimr They altn rhowed a time 6ap 
betw-x npaesion of VCAM-I between endotbelial relb 
where it qpmxs sithln the Smtw.ek,aodsmmth muvlecelk, 
witichdonotaweuuntilafter6weeksdatbzmzenkdisr 
Expression t&AM-i and the peaence of T oells>n atkzm- 
s&rot;- Plaque suggest bnt immunulugic wnts mediated b 
cell adl&m molmdes may play a mlc in the pmgraion of 
uhemsckmsis. In addit& on the basis uf the time gap of 
VCAM-I ex~assion between embthelium and rmanh mu& 
cell, VCAM-I may !x il mnrker for “actiwdion” of smwth 
mwlc cdk 
As a result of increased cell ndhaimt molccuks on the 
activated endotbelittm. binding of leukwyt~~ and numwytrs k 
patentiatcd 5mnc yiokines 01 ewn the modified lipids mny 
M as monccyte chcmoattrwtan~ wbiih allow momnytcr to 
enter the imima by squeezing batwen andotheliul crllr. 
.Scbwtz et 01. (68) showed that monacytic migratian into the 
submdc4klii spaa through cell junctions ucarxd in ru- 
sponse to cbmmattmctants that may k Present in the intima 
OT lncdia of the wmel wall. Using an mttibody pmlx. Muller et 
ill. (69) sbowmi the importance of PECAM-I in tnnsesdothe- 
liol migrmkm of kukocyxes. The macwphagcs in tk sukndo- 
thclial layer ban been sbmvn to prcdu~c wend gmwth 
factom, rucb m platelctderiwd gm*vth facta (PDGF) (70) 
and tnrfwminggrwtb factor (TGF) (71). Monacytedeciwd 
ToT_B stimulates matrix pwduction by smooth mule cells 
(72). Then smooth muscle cells arc surmmt&d by the cxtm- 
cellular matrix. whicb is cmtqmsed of tibmnectin, hminin and 
col@ ~pcs I and N (73). Ilmse extraccllular nwtrk 
pmccins am mdy pmmoac ell adhesion and migration (74) but 
aka btRumuc tbe ~benotypic trmnfommtion of the smooth 
mu& cell (75) by means of the &intcgrin subfamily. ti- 
bmne&. widcb is incraved in arthemscltir. p:omota 
modulation of tlm smooth mm& cells from a contractile to 
synthetic Phenotyp;. wbercas laminin has the opposite ctTect 
(76). The &-inkgrins permit smooth musk cells to attach to 
sppeu to be lilnaional “II pkteleu * rest and thus are ready 
to mediitc plateIn binding to atmcollular matrix (Fl6. 4). 
Under oonoal cbcomsmoces, the inmct eodothelium seqow 
ters the adhesive dympmteio FFF (e.g. xx! Wilkbraod 
factor, fibrow& and collagen) horn the platelet in the 
sobendothclium, thus prevm~ platelet adhesion in the 
akznce of vasadar damage. GPlllX mediates the hdtial 
binding of pktekts at rest to voo WFlkM factor. Tbk 
baemctkn i&a the transition of GPffb/llfa from an ioac- 
tive to M a&e state, wbkb kad¶ to platelet agcegation. 
Platelet -ion ir mediated by lipnd binding to GPUb/ 
Ilk. L? cootma to the other pktekt rcqtors, this & integrin 
captor is preant in 811 unactkated state oo pktekts at test 
(2). Go plntekt ahmdation with oom~rrm a&mists. GPflb/ 
Ilk baonwr actkawd such that it can bind fibriqa and 
scveml otbcr l@uls, including fibraw& vitmncctin. van 
Wilkbmod factor mod tbmmbospmdin. The octiwtkm nod 
occopaocy of GPfMlla k the final cammca pathway ladin 
to platekc ogrcgatkm. A oombcr OF Pgonins can case 
cxpowe d GPflb/lUo arid pktekt qgq&on, eveo if the 
uaehii Mid pathway is wmpktcly blabed by aspirin or 
other inhibiton 
Recently, bhxbdc of GPllbnlfa he bceo intensivebj sN& 
kd u oo ap~wwh to aotipkbzkt tbcmpy. The modor mom 
donll nn6body 7R3. developed Ly C&r (62), bbch tbe 
GPflMlfa rcce@or. The P(ob’h or Fob fm6mmt of tbk 
olllibody coo ~pkle~ bbfk @t&t aggI’C@iOn inhrcd by 
all qcnts Lmtb 01 vko and in viva (63). In o pikt stody witn 
7E3, Go&i et ol. (64) showed on cwoora6io6 redo&n of the 
prccors of inmoth mu?& celimigntion tbc ihoroxlnotk 
ns well fa reslenotic process (62). 
Certain viral infectii of endothelkl ceFk have ken shown 
exores&m (771. These In vitm Aodingr~wwi w&biFFty 
of’s mk Foi viral i&lion in the paiho6&&h of aihcmrl; 
mk, 8s has been propad by sweml investigators (76.79). 
With the lipid bypothcsir of athomsckmsk, the thmmba- 
genie or bwostation theory FMJ.61) sowsts the lmwnancc of 
ihtombork in the dew&&m 2 a&osckrolie’l~ as 
wll as phdekta as o ~)orce of scwal smooth muck celF 
mitogcm. The roles of cell adhesion mokcoles for inlcrcellulr 
adherjon he&em platelet and endothclivm nod platekt sod 
leakocytc we discowd later. 
Thmmbosis 
The mlc of thrombur In the othemsckrotk and restcootk 
pnrcca afler comnmy nn.giopk&y is sigoihant and k central 
in acote myocordial infarction. Cell adhesion mokcuks ore 
way wilh leukocyte integrins and lb&b pktekiodh& and 
a6gqolion rvith p,- and &inlegrin. 
Pktekt mod c+ll adbeslw mol&. Plarekts contribotc 
to nomml hemosbw by adhering to sobcndothclkl sotfaces 
oiler blood ~~ssek have been damaged and then r@ycptiog to 
fo;m o thmmbos (15). Pktekls possess II number of alI 
adhesion mokcokr. such as fl,- and p,~integrinr, Packctbl 
(CD62). PECAM (CD31. o mcmlxr of immoMglobolin lam- 
ily) and CD36 (d~mtein IV, o receptor for coll~en nod for 
thrombospondio) (56) (Table 4). 
The many weptors iovoked in platelet ndhesii such 8s 
GPlaillr (a@,)_ GPldlla (&, 6bmncctin receptor). GPk’/ 
umabk angina compmd with th& raoivin6 @aceb;. 
KkhoooetaL(Pa)prformaithepilotModyoftbeTbrmn 
bdysis and AngFoplasty in Myoadkl Infmc6on (TAM)-6 
trkl oko usin# 7E3 and zhcwd impoved vessel patency owl o 
teodeocy toward lcsa freqoent recotrent kcbcmk 24 h afta 
tbmmbotykTheantiioppmachhasaboLxasbownin 
cxpcrlmcntal mod& to shmten the time to achkw thrombol- 
pk and prewnt re4nzl~ion (83.66). 
The Evaluation of 7E3 In the PreventIon of kchcmic 
ComplicatFon (EPIC) (87) bial, a doobk.bfind plrebo- 
mntmlkd lrkF of 2,6!J9 patimts under&+ high rkk coomary 
~n&platy twoted with c7E3 (chbocrk Fob), demonstrated o
35% reduction of mlpr ixhcmk cveots (dath. oy:mdiol 
inftuctkm, or@ol rcwctda~) at I mooth for Ihe floop 
recetin6 a bdur and wbiquent 12-h Ior, dose iofosbm of 
c7E3 compucd with those rcaiviog pkcebo (Pii 5. top). Tlds 
k the Aru demonaraioo in ptiims of n thenpeotic UK for a 
qecit7c inhibitor of a roll adhesion owlecole. 
A nomber of peptidr and nonpcp(ide mimetic agents that 
inhibit the GPffbNla receptor are being evoluted in clinkal 
triak. Exampled inch& lot&in (COR Thxapeutks). a 
KGD @ic hc@apep!ide and the small-molecole oonpeptidc 
mhoetic agmts. includiq the RGD MK-.XU (Mercb, sharp & 
Dohmc) ood RG44 (Ho%imo.LiiRcche, Yosel. Switzerkod). 
Rapid dcaraoa and revenibility ofthex drug. in contmst o 
Ila (u& laminin receptor) and a& (vitmnc& raptor), the on~llwdy. arc possible benefits that mig!! allow for tioe 
Edington (R! shaved that monwytes can din+ activate 
factor X :?i Xa &et binding this rymogen tu a CDlILCDlB. 
Tbrombin generated by the mrgdation cascade induces a!$ 
greption UI pirtekts to inidatc thrombus fommtion and 
r&are ir%m;lahvy mediators from pkdelet gmnulcs (96). 
~hnm.. .:: &u is a potent ehemoattrectent for monocytes and 
smonth muscle sells (91). 
By amwest, di6erei memhea of this cktxs 2 agc~ts cxkibit 
diSerent binding cheracteristira and reletbe speeifkities. For 
cxsmpk, c7E3 ala binds to the vitmnectin receptor. which 
my be an important httegtin in this retbng. hut lntegtelin does 
not. The isswe of intentin soecilicitv will need to lx clarified in 
filhrerhld*r - . . 
Ike colg*lluo aysten cad eelI adheslm mokeules. Re- 
cently, there have ken a few repark of the role of leukwytc 
im&ts in thmmkas fomtation. Roth CDllbKDllJ and 
CDlWCD18 ate &tfnogen receptors cxpresxd by Iculmcyte-~ 
Bindial of CDllblol8 with immobilked tlbrinogen induces 
,bc t,&+im of the tissue factor gene in-mvnocyta 
resulting in sutface membmc ~~uiun of tissue bctor and. 
mnsequemly, the pnxoagulant activity of these cells (88). In 
to initiate magtdation and g&r& thmmbht. All&i 
Kcstunosir; is believed to vault from a complex intemction 
of thmmbarir cellular pmlifer;ttion and ekutic mail (92). 
Thhrec phaxr for dewloping intimal hyperpl;lrin folkwing 
veal injury bared on the experiment4 models (57.93) we 
purtukucd. The fimt phesc ischmacterized by an infl;lmmaw 
respannrc inwlving the recteitment of leubcytcs to the rite of 
injur end by the fotmatiun of thmmbus in the tiot W h. A 
hound matrix. which contains platelets. fibritu~en. fibrin and 
libmncctin. cases an intimmatow reaction atd induces the 
r~rav;lraion of kukocytes. cyt&iec rclcac. scctction of 
wriva gnwth f.actots and further pneration of thmmbin at 
the xitc of injury. Through tlur ma&w. cndothclium is 
xtiwtcd with the expmssion of adhesiot~ mulwulex ICMI-I. 
Eaclectin. P-selmin and VCAM-I. end mxropheges and 
IibnMwtr hegin to mipmte into the iquv ritr by mmmr of 
vp-regulstiun of integina (94). Di Cotleto and de la Nutte (9S) 
akw xhowcd that thmmbin stimuhted monvcj~e adhesion to 
cedahclid cells. probably by triggering expression of P- 
selectin on the enduthelial surf~cc (%). Thus thrumbin gen- 
emtinn OLYX~ through the coagulation cascade. end there is 
recruitmcnl of i ddhionel monwytes and platelets end pmmo- 
tkm of further platelet aggtegatiun. Plgelet binding to the 
cxpuxd matrix potentials invuiws the fl,- and &integrins as 
wll as Gl’ib (6). 
The second phase is chemcteiized by the pmlifcntian of 
smwth me.. oclls in the vessel media end the m$r;ltiun of 
these cells into the intima. whcte they may pmlifemtc. Plntelet 
aggteefion and pnemtion of thmmbin at the dtc of mterial 
disruption may be important in initiating cellular gmwth 
apccielly of smcath muscle cells (97X4). The gmwth faclom 
end cytokina that promote the pmlifemtion and migmtion of 
smuath muscle cells ate relmrcd from the plntelet the leukc- 
cyte end ewe from the smooth muscle cells. Multiple 8,- 
integriw. v&h can aEat the stnbiliiy of smooth muscle cell 
binding to extrecellulat matrix. err thought to be invcdvcd in 
the pmesr of smooth muscle cell migration (6% 
The last phase is the secretoty phase of extmcclhdor metrix 
fmm smcah mus& cells comprising the ncointima Although 
the relation hehwn extracellular mnt:$ and cell adhesion 
molecules in this phue is not well known at preJent, further 
studies msy disclose the role of cell adhesiun molccula in the 
rccmtoly regulation of smooth muscle cells. 
During the L-month clinicd folhxv-up in the EPIC trial 
(99). there was o significant 238 reduction in the incidence of 
iazhemic events. The favorable long-term effect was mainly B 
result of less need hx masculatization in patients with an 
initially wca&d procedure (Fig. 5. bottom). The redoctioo h 
long-term mou after a bolos and 12-h infusiin in the acotc 
phase wggesk that the phenomenon of uterial “passiwtiott” 
hastabmplacc.apmeeslbywbichtbeartwialrorfaceh 
tmnsformcd IICCI one that supports platelet deporition to ooe 
that &es oot. ndb is the Rtst largcalk trial to shav B 
si@caot decrease in dinical mslumia with a pharmaoalogic 
inlerwntion, rdkacd bj a deereace in cargel wsel tewcw 
larimtiou This finding sqgesu that platekl GPIIbilUa inte- 
gin blockade maybe a wfol adjooct to reduce the thmmbotk 
raoimse cootwoe* of vascolar initnv. Huaver. it remains 
lfkhy that an’aot&oliferative &o&b, dlreded M smwth 
mwle cells. will also be occcsza~y. fartwsak trkls of 3.096 
Repc&don Injwy 
RepedosNo htjwy btwlws calciom overlwdipg htN celk 
after monlgcnalion of ixbemk myocardium. Resided tbc 
action of calcium. the mle of kukocytcs in reperfmlon injury 
bm beeo ex~eosively rutdied including the ccmeibotion of 
thge celk M free dii @m&n sod capillary -6. A 
numba of studies have shown that &pk&m or qqmssbm of 
leokwytc fonetion can redwe the repcrfosion injtuy, ineludiy 
aotipolymorpbomtckar leukocyte an6bodk.s (Ml), cxtmcor- 
pmeal tilw‘timt m - polymorphaluckar leukoqta 
aa&flmma0ry ageas (102). i a SmJy by Yoir a al. 
(Ig, it was eaablkhed that the indoctiat of kobcqte 
adhaeoce lo the cardiac myocyte was promoted d&t9 repec- 
fusion. Although the mechanism of cdl death ht reperfosioo 
injury is still not dear, the role of cell adhesion m&cola is 
implkated in kubocytc sdhesioo and bt6ltmtion u well a~ 
p&ocytais. Adhe& mokcoks boom to paMpa~e In 
tbac ma&m are grouped in tbrce Lxoad hmilia* 
Yammki et al.(J) shancd In the ra coronaty artery 
ligation mod& that pntreatoxnl with moaoehmsl antibodks 
qaim CDII,. CDII,+ CDII, CD18 and ICAM- per- 
formed 5 min before comnmy occlti reduces the ntyocar- 
dial infarction ske (6.1 + 1.74 10.1 + 2.1%. 19.6 t 3.6%. 
13.8 f. 23% rq&tiiely. compared with the cootml9ro”~ 
343 + 4.2%. o < 0.031. A sludv carried out bv Ma et al. 11051 
in a cat tep&sioo m&l al&showed that &inLwati~o 2 
Y moowkoal antibody against ICAM- 10 min before rcper- 
fusion Icads to sigoifi~mly lcwr myucardial occmsk than 
o+xon in motrd animals (IO + 2% vs 28 f 2% of kB 
vcotric~lar aa at risk, p < 0.01). In cmlrasl lo the positive 
rcsultsobtainedwitb leubowte intwin and ICAM-I block& 
the:* is some mntwersy ~&a&6 the mk of selection in 
repotfusion injury. Wey?kh et al. (106) demoostnted that a 
mooockoal antlbody to P-sekctin attenuated the pdymotpho- 
nudoar kobcqte adbermce to mdotheliom and exerted 
signi6caot eodotbelial prescrvatioo nod cardiopmtcctioo in 
m~cardial kcbemia and repmfusion in cat reperforion model. 
fiwevfz Komse et al. (107) &owed that a momdonsl 
aon* against P-sdstin or E-&&t did oat reduce the 
leobqte-eodothelkl adh&, abboogb the aotii agaiost 
Gsckctio was e6cctii fo a rat reperfwioo omdeL Receo!ly, 
potuuial oscs of ao am&g glycoside of the wbobydnte 
stroctum sklyl-L&s X a an aotiadhaive a@ mre sug- 
gested in no eq!abocnml model (19.26). 
iutbou6baoomberofblqoMtissucssudlas~tyMd 
sideeKea&bavemtyetboaddMcdinimti-CdMbc&m 
mokaks therapy, selected momelooal antibodks or peptide 
inhibitors agabtst cell adhesion mokadc~ wff be bwcstigalcd 
in dinkal tih in mmhinatimn with a@@asty or rhrmbd- 
pi& 
Aliogm~I Vasctdopathy in Gdiac Tmnspfamation 
Allo&t vasmdar disease. a” accckmted form of comoaiy 
direare that danoosa?dcs similar patbolo6ic 6odiogs m those 
of rmfy taenosis after m@pksty (108). - in heart 
tmmpkttt Kcipkna Amcq the vmfow possible medlaoisoS 
of this dirslac. wbicb include cbe administration of bomuoo- 
sopp+ve -IS socb s cortleoacmids, whkh prodwe a 
eolrarm(ra( Iqrpallpoprot&mk, vlnl b&tfoos sod kxh- 
emk Injury of cownary artery cndothelhoo caoniog bebwm 
barvest ad r&pkntatfw, immune reactioo to e&thdial 
eelllotthccngsf\cdvgiclksmplcdnsoneofthcmain 
LlahoMnetk lci0xn 1109). 
Ti6 pmenc&f m;rmbhagcs sod T lympbocytm in tmw 
oknted mmowv snerks f1W and the detection of PDGF at 
ihc SiN of dipmlilc~h'(l10) impliaN cylokhms and 
grcaihfac&usblallo6mftvascokplthy.~~~~thc 
gmwtbfaaompmmotemam@agercendcmclusndrtiva 
tica, pmlfferatioo of smooth mnsck cells and eatta~llolrr 
mark qmbesb by sntootb m&e cdls (M), wMcb arc pota- 
tiwly mediated b cdl adhcsbm m&cola 
Sewal t.Ndlcs (Ill-113) hsvc demotwMed that exprek 
rion of ICAM- nod VCAM-1 in capillpillda fouacd with the 
severity of cdlulu rejcaion and was pmmbtent in homcanl 
attti&AM-1 (Hi) and attti-‘f&M-l attltbDdy illj):lhcsc 
prcduxd prolonged gmft rurvival w&out other immunosup 
piwko aod sobggl that block& of leukocyte odhesioo 
mokcoks stay hold prom& as a therapeutic mmklity for 
cardiac allogmft vmtby. 
Cell adhcsiw mokcoks arc a goup of chedy related 
&mpmteins preseot on a wide vdrkty ofcclk. The erprcraion 
and foncUon of rhge mokcuks M influenced diratly and 
indhcctly by cyraljnes, pwih facton, free rxlkal~ and intm- 
.XllulsrevmgXldndthCmleOf4lUdh&llllllOkXUkSlintilC 
regulation of cellular fun&m must be interpreted to the 
cootext of tbge eovimomeotal stbodi. lo addition to xrviog 
as a means of cuzgnizing and responding to cnkmnncntal 
changes. cell adhesion molecules also mntml various cell 
responses such as chemutais. migration. differentiation and 
phagcqiosk Tbhus these mokcuks may play important mler 
in diien~~ disease pmccsscs. including athcmsclerusis. mro- 
nay thrombosis rertenolis atkr ~ercutanr~~~ curonarv reva+ 
comprehensive understanding of the mole&s and their func- 
tiara simdd pmmotc the development of bikgi4y reltwm 
and poxntially more elkctiw thcrapcuiicr in the ncx future. 


